Dana C. Matthews

6.2k total citations · 1 hit paper
70 papers, 4.3k citations indexed

About

Dana C. Matthews is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Dana C. Matthews has authored 70 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 26 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Oncology. Recurrent topics in Dana C. Matthews's work include Radiopharmaceutical Chemistry and Applications (19 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Lymphoma Diagnosis and Treatment (14 papers). Dana C. Matthews is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (19 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Lymphoma Diagnosis and Treatment (14 papers). Dana C. Matthews collaborates with scholars based in United States, South Africa and United Kingdom. Dana C. Matthews's co-authors include Oliver W. Press, Irwin D. Bernstein, Janet F. Eary, Frederick R. Appelbaum, Darrell R. Fisher, Paul J. Martin, Rainer Storb, Bruce A. Porter, S. Glenn and Lawrence D. Durack and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Dana C. Matthews

68 papers receiving 4.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support

1993 512 citations Oliver W. Press, Janet F. Eary et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dana C. Matthews United States	26	1.8k	1.5k	1.3k	1.0k	757	70	4.3k
Norbert Frickhofen Germany	27	566 0.3×	1.4k 0.9×	883 0.7×	882 0.8×	536 0.7×	79	3.8k
Alessandro Levis Italy	32	570 0.3×	1.1k 0.7×	2.1k 1.6×	1.3k 1.2×	616 0.8×	100	3.8k
Hiroo Dohy Japan	23	546 0.3×	1.3k 0.9×	390 0.3×	628 0.6×	493 0.7×	61	2.8k
Theodore A. Gooley United States	40	607 0.3×	3.5k 2.3×	634 0.5×	1.5k 1.4×	1.0k 1.4×	86	6.0k
J. S. Malpas United Kingdom	36	492 0.3×	1.7k 1.1×	1.2k 0.9×	1.9k 1.8×	675 0.9×	109	5.5k
Nicolas Ketterer Switzerland	23	549 0.3×	1.1k 0.7×	2.8k 2.1×	2.5k 2.4×	1.4k 1.9×	69	4.5k
David C. Fisher United States	45	415 0.2×	1.4k 0.9×	2.9k 2.2×	2.1k 2.0×	1.9k 2.5×	192	6.2k
Ricardo Spielberger United States	27	359 0.2×	1.3k 0.9×	434 0.3×	1.4k 1.4×	351 0.5×	84	3.5k
Robin Joyce United States	26	848 0.5×	811 0.5×	1.4k 1.1×	1.5k 1.5×	656 0.9×	94	4.0k
Auayporn Nademanee United States	39	373 0.2×	3.1k 2.1×	3.2k 2.4×	3.3k 3.2×	1.3k 1.7×	180	7.3k

Countries citing papers authored by Dana C. Matthews

Since Specialization

Citations

This map shows the geographic impact of Dana C. Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana C. Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana C. Matthews more than expected).

Fields of papers citing papers by Dana C. Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana C. Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana C. Matthews. The network helps show where Dana C. Matthews may publish in the future.

Co-authorship network of co-authors of Dana C. Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Dana C. Matthews. A scholar is included among the top collaborators of Dana C. Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana C. Matthews. Dana C. Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCarthy, Elizabeth, Amy L. Chadwick, J.J. Soto Castillo, et al.. (2025). A multi-centre review of the use of adjuvant pembrolizumab for renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 484–484.

Spence, Matthew A., et al.. (2024). Rugged fitness landscapes minimize promiscuity in the evolution of transcriptional repressors. Cell Systems. 15(4). 374–387.e6. 5 indexed citations

Delaney, Meghan, Joan Roberts, Nabiha H. Saifee, et al.. (2018). Bleeding emergencies in neonatal and paediatric patients: improving the quality of care using simulation. Transfusion Medicine. 28(6). 405–412. 2 indexed citations

Leavey, Patrick J., Joanne M. Hilden, Dana C. Matthews, et al.. (2017). The American Society of Pediatric Hematology/Oncology workforce assessment: Part 2—Implications for fellowship training. Pediatric Blood & Cancer. 65(2). 15 indexed citations

Hord, Jeffrey D., Mona D. Shah, Sherif M. Badawy, et al.. (2017). The American Society of Pediatric Hematology/Oncology workforce assessment: Part 1—Current state of the workforce. Pediatric Blood & Cancer. 65(2). 23 indexed citations

Delaney, Meghan, Dana C. Matthews, & Terry Gernsheimer. (2017). The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. Pediatric Blood & Cancer. 64(12). 1 indexed citations

Cameron, Ewan, et al.. (2016). Undergraduate radiology teaching in a UK medical school: a systematic evaluation of current practice. Clinical Radiology. 71(5). 476–483. 23 indexed citations

Ettinger, Ruth A., Eddie A. James, Maochang Liu, et al.. (2015). Factor VIII gene variants and inhibitor risk in African American hemophilia A patients. Blood. 126(7). 895–904. 39 indexed citations

Matthews, Dana C.. (2013). Inherited Disorders of Platelet Function. Pediatric Clinics of North America. 60(6). 1475–1488. 9 indexed citations

10.

Pagel, John M., Theodore A. Gooley, Joseph G. Rajendran, et al.. (2009). Allogeneic hematopoietic cell transplantation after conditioning with 131I–anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome. Blood. 114(27). 5444–5453. 122 indexed citations

11.

Wise, Robert P., Jan Bonhoeffer, Judy A. Beeler, et al.. (2007). Thrombocytopenia: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 25(31). 5717–5724. 21 indexed citations

12.

Mohit, A. Alex, David J. Fisher, Dana C. Matthews, Eric K. Hoffer, & Anthony M. Avellino. (2006). Inferior vena cava thrombosis causing acute cauda equina syndrome. Journal of Neurosurgery Pediatrics. 104(1). 46–49. 23 indexed citations

13.

Sierra, Jorge, Barry E. Storer, JA Hansen, et al.. (2000). Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplantation. 26(4). 397–404. 159 indexed citations

14.

Matthews, Dana C., Paul J. Martin, Cynthia Nourigat, et al.. (1999). Marrow Ablative and Immunosuppressive Effects of131I-Anti-CD45 Antibody in Congenic and H2-Mismatched Murine Transplant Models. Blood. 93(2). 737–745. 2 indexed citations

15.

Press, Oliver W., JF Eary, Peter J. Martin, et al.. (1994). PRELIMINARY RESULTS OF A PHASE II TRIAL OF IODINE-131-LABELED ANTI-CD20 (B1) ANTIBODY THERAPY WITH BONE MARROW RESCUE FOR PATIENTS WITH RELAPSED B CELL LYMPHOMAS. Journal of Immunotherapy. 16(2). 160–160. 8 indexed citations

16.

Press, Oliver W., JF Eary, C Badger, et al.. (1993). RADIOLABELED ANTIBODY THERAPY OF RELAPSED B CELL LYMPHOMAS. Journal of Immunotherapy. 13(1). 70–70.

17.

Matthews, Dana C., Franklin O. Smith, & Irwin D. Bernstein. (1992). Monoclonal antibodies in the study and therapy of hematopoietic cancers. Current Opinion in Immunology. 4(5). 641–646. 1 indexed citations

18.

Appelbaum, Frederick R., Dana C. Matthews, Janet F. Eary, et al.. (1992). THE USE OF RADIOLABELED ANTI-CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA. Transplantation. 54(5). 829–833. 126 indexed citations

19.

Press, Oliver W., Janet F. Eary, Christopher C. Badger, et al.. (1991). Radiolabeled Antibody Therapy of Human B Cell Lymphomas. Advances in experimental medicine and biology. 303. 91–96. 7 indexed citations

20.

Bargatze, Robert F., W. Michael Gallatin, Dana C. Matthews, et al.. (1988). Homing Receptors and Metastasis. Advances in cancer research. 51. 361–390. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact